Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk

Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Liraglutide reduces mortality (NNT = 71) in patients with T2DM and very high CV risk ID - 1314080 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314080/all/Liraglutide_reduces_mortality__NNT_=_71__in_patients_with_T2DM_and_very_high_CV_risk PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -